+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Whole Plasmid Sequencing Market by Component (Consumables, Instruments, Services), Technology (Nanopore Sequencing, Next-Generation Sequencing, Plasmid-EZ), Sample Type, Application, End User - Global Forecast 2025-2030- Product Image
Whole Plasmid Sequencing Market by Component (Consumables, Instruments, Services), Technology (Nanopore Sequencing, Next-Generation Sequencing, Plasmid-EZ), Sample Type, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Whole Plasmid Sequencing Market by Component (Consumables, Instruments, Services), Technology (Nanopore Sequencing, Next-Generation Sequencing, Plasmid-EZ), Sample Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055275
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Whole Plasmid Sequencing Market grew from USD 127.35 million in 2024 to USD 136.66 million in 2025. It is expected to continue growing at a CAGR of 7.71%, reaching USD 198.88 million by 2030.

Whole plasmid sequencing has emerged as a pivotal technology in modern genetic research and diagnostics. Recent advancements in sequencing tools have enhanced our ability to decode entire plasmid structures with greater precision and speed. This breakthrough is not only revolutionizing the way we understand bacterial genetics and resistance mechanisms but is also laying the foundation for tailored biotechnological applications. As research continues to expose the intrinsic complexity and dynamic nature of plasmid DNA, both academic and industrial entities are rapidly integrating these new tools into their workflows. Increased throughput, improved accuracy, and the ability to process multiple samples concurrently have made sequencing a robust element in both research and clinical settings. In this evolving landscape, the new generation of sequencing technologies is bridging the gap between traditional methodologies and modern demands. The importance of whole plasmid sequencing is underscored by its role in expediting discoveries in microbial evolution, pathogenesis, and therapeutic interventions. Driven by the need for rapid, cost-effective, and reliable data, the industry is witnessing a significant paradigm shift. This report delves deeper into the dynamics that influence market changes and strategic recommendations for stakeholders, setting a stage for future innovations.

Transformative Shifts in the Landscape

The landscape of plasmid sequencing is undergoing transformative shifts that are reshaping the industry. The advent of next-generation sequencing platforms, coupled with improved computational biology techniques, has enabled unprecedented levels of data integration and accuracy. These technological revolutions have, in many ways, expanded the boundaries of research, leading to deeper insights into plasmid biology and its applications in genetic research. Traditional barriers such as cost, time constraints, and scalability limitations are quickly being overcome through continuous innovations. Companies have leveraged these technological advances to refine existing processes and introduce novel methods capable of addressing complex genomic structures. Driven by a combination of research impetus and clinical necessity, players in the market are now better equipped to understand both the macro and micro aspects of plasmid functions. This shift is further propelled by an emphasis on data-driven decision making, where large datasets are harnessed to derive meaningful insights about genetic mutations and disease diagnostics. In summary, the evolving technological framework is fostering a more interconnected and efficient environment, paving the way for rapid deployment of next-generation diagnostic tools and biotechnological applications.

Key Segmentation Insights

Market segmentation in whole plasmid sequencing provides a multi-dimensional lens through which the industry landscape can be view. When analyzed based on component, the market is dissected into consumables, instruments, and services. Within consumables, elements such as library preparation kits and reagents stand out as foundational, while the instruments segment is further refined into analyzers and sequencers that drive sample processing. In addition, the services segment, which includes both data analysis services and sequencing services, is evolving rapidly with technological adaptation. From a technological standpoint, the market is segmented into Nanopore Sequencing, Next-Generation Sequencing, Plasmid-EZ, and Primer Walking. These technologies serve different research needs, underscoring a diverse array of solutions tailored to specific genomic challenges. The segmentation based on sample type further illustrates market dynamics as research expands to include varied biological specimens like blood, saliva, and tissue. Moreover, the application segmentation differentiates between disease diagnosis and genetic research, with disease diagnosis further bifurcated into areas like cancer research and neurodegenerative diseases, and genetic research divided into gene mapping and mutation detection. Lastly, examining the end users, the market comprises academic research institutes, biotechnology companies, clinical research organizations, and pharmaceutical companies. These detailed segmentation insights offer a granular perspective on target audiences and niche areas of growth within the sector.

Based on Component, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Library Preparation Kits and Reagents. The Instruments is further studied across Analyzers and Sequencers. The Services is further studied across Data Analysis Services and Sequencing Services.

Based on Technology, market is studied across Nanopore Sequencing, Next-Generation Sequencing, Plasmid-EZ, and Primer Walking.

Based on Sample Type, market is studied across Blood, Saliva, and Tissue.

Based on Application, market is studied across Disease Diagnosis and Genetic Research. The Disease Diagnosis is further studied across Cancer Research and Neurodegenerative Diseases. The Genetic Research is further studied across Gene Mapping and Mutation Detection.

Based on End User, market is studied across Academic Research Institutes, Biotechnology Companies, Clinical Research Organizations, and Pharmaceutical Companies.

Key Regional Insights

The regional analysis of the plasmid sequencing market offers pivotal insights into the geographic variability in market adoption and growth. In the Americas, the robust presence of advanced technological infrastructure combined with substantial research funding has underpinned market expansion. Stakeholders in this region continue to invest heavily in research and development, thereby accelerating the pace of innovation and the uptake of new sequencing technologies. Turning attention to Europe, the Middle East, and Africa, a combination of established academic institutions and burgeoning biotech ecosystems is driving market penetration. This region exhibits a unique blend of regulatory support and strategic collaborations between public and private sectors, thereby catalyzing growth. Meanwhile, the Asia-Pacific market is characterized by dynamic economic expansion, a significant focus on technological advancement, and increasing investments in personalized medicine and diagnostics. The rapid industrialization and growing healthcare expenditures in this region are fueling a significant demand for high-throughput sequencing solutions. Each of these regional markets demonstrates distinct trends and opportunities, thereby fostering a competitive environment where localized strategies can effectively drive innovation and market growth. These differentiated regional dynamics are crucial for stakeholders aiming to tailor their strategies to specific market needs.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

A close examination of the competitive landscape reveals a network of companies that are shaping the future of whole plasmid sequencing. Leading organizations such as Agilent Technologies, Inc., Azenta Life Sciences, and BaseClear B.V. have demonstrated a steadfast commitment to technological innovation and operational excellence. These companies, alongside industry pioneers like BGI Genomics Co., Ltd. and Bio-Rad Laboratories, Inc., are continuously developing state-of-the-art platforms designed to deliver rapid and accurate sequencing results. Further bolstering this competitive field are players such as CD Genomics, Danaher Corporation, and Eurofins Genomics LLC, who have strategically positioned themselves at the nexus of technology and service excellence. The strategic market positioning is complemented by contributions from F. Hoffmann-La Roche AG, GenScript Biotech Corporation, and Illumina, Inc. In addition, organizations like Integrated DNA Technologies, LGC Biosearch Technologies, and Macrogen, Inc. have been instrumental in pushing the boundaries further. Companies like New England Biolabs and Novogene Co., Ltd. continue to drive innovation while other significant entities such as Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Personalis Inc., and Polyplus-transfection S.A. offer a diversified array of solutions that cater to various end-user demands. Not to be overlooked are Qiagen N.V., Synthego Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc., each of which is contributing to the transformative growth by actively engaging in research collaborations and technological investments.

The report delves into recent significant developments in the Whole Plasmid Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Azenta Life Sciences, BaseClear B.V., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, Danaher Corporation, Eurofins Genomics LLC, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, LGC Biosearch Technologies, Macrogen, Inc., New England Biolabs, Novogene Co., Ltd., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Personalis Inc., Polyplus-transfection S.A., Qiagen N.V., Synthego Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc..

Actionable Recommendations for Industry Leaders

For industry leaders looking to capitalize on the evolving whole plasmid sequencing market, a number of actionable strategies can be employed to maintain competitiveness and drive growth. A prime recommendation is to invest in the development and integration of state-of-the-art sequencing platforms that combine high accuracy with rapid turnaround times. By prioritizing research into novel consumables and instruments, companies can reduce operational costs and improve the overall user experience. Strategic collaboration between research institutions and technology providers is another critical measure. Such alliances can expedite the incorporation of cutting-edge innovations into workflows, thereby shortening the development cycle of diagnostic and research applications. It is essential to harness advanced data analytics in order to glean deeper insights from sequencing outputs, which in turn can inform more targeted and effective product development. Simultaneously, industry leaders are advised to monitor regulatory trends across key markets, ensuring compliance whilst advocating for favorable policies. Diversifying portfolios and expanding geographic footprints - particularly in fast-growing regions within the Asia-Pacific - can also yield significant returns. Leaders should adopt a proactive stance by engaging with opinion leaders and investing in training programs to upskill teams, thereby ensuring that the latest technological advancements are effectively utilized to meet emerging market demands.

In summary, the whole plasmid sequencing market is at a pivotal juncture, characterized by rapid technological advancements and a competitive, multi-segmented landscape. As detailed segmentation and regional insights illustrate, varied components such as consumables, instruments, and services, along with diverse technological approaches, are collectively enhancing market depth. The regional disparities - from well-established markets in the Americas to the swiftly growing sectors in Asia-Pacific - underscore the global reach and strategic importance of these developments. In addition, influential companies across the spectrum are driving innovation and fostering a culture of competitive excellence. The synthesis of these factors, combined with the need to continuously adapt to evolving regulatory and technological environments, presents a complex yet promising pathway for both established players and new entrants. Ultimately, the market is poised for substantial growth, spurred by synergistic collaborations, strategic investments, and a resolute commitment to scientific advancement.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of genetic disorders
5.1.1.2. Growing demand for advanced genomic research techniques in biotechnology sector
5.1.1.3. Government initiatives promoting research and development in genetic engineering and biotechnologies
5.1.2. Restraints
5.1.2.1. Stringent regulatory compliances for deployment of whole plasmid sequencing technologies
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in sequencing technologies
5.1.3.2. Surge in funding and grants for advanced research in sequencing technologies
5.1.4. Challenges
5.1.4.1. Availability of alternative sequencing techniques
5.2. Market Segmentation Analysis
5.2.1. Component: Rising preference for instruments for decoding complex plasmid structures
5.2.2. Application: Increasing significance of whole plasmid sequencing for cancer research and neurodegenerative diseases
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Whole Plasmid Sequencing Market, by Component
6.1. Introduction
6.2. Consumables
6.2.1. Library Preparation Kits
6.2.2. Reagents
6.3. Instruments
6.3.1. Analyzers
6.3.2. Sequencers
6.4. Services
6.4.1. Data Analysis Services
6.4.2. Sequencing Services
7. Whole Plasmid Sequencing Market, by Technology
7.1. Introduction
7.2. Nanopore Sequencing
7.3. Next-Generation Sequencing
7.4. Plasmid-EZ
7.5. Primer Walking
8. Whole Plasmid Sequencing Market, by Sample Type
8.1. Introduction
8.2. Blood
8.3. Saliva
8.4. Tissue
9. Whole Plasmid Sequencing Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.2.1. Cancer Research
9.2.2. Neurodegenerative Diseases
9.3. Genetic Research
9.3.1. Gene Mapping
9.3.2. Mutation Detection
10. Whole Plasmid Sequencing Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Biotechnology Companies
10.4. Clinical Research Organizations
10.5. Pharmaceutical Companies
11. Americas Whole Plasmid Sequencing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Whole Plasmid Sequencing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Whole Plasmid Sequencing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Scenario Analysis
14.3.1. Oxford Nanopore Technologies and Plasmidsaurus team up to enhance plasmid sequencing with advanced nanopore technology.
14.3.2. seqWell transforms synthetic biology with ExpressPlex HT enabling ultra-high throughput plasmid sequencing
14.3.3. Eurofins Genomics enhances genetic research capabilities with new Seattle lab utilizing Oxford Nanopore
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. WHOLE PLASMID SEQUENCING MARKET MULTI-CURRENCY
FIGURE 2. WHOLE PLASMID SEQUENCING MARKET MULTI-LANGUAGE
FIGURE 3. WHOLE PLASMID SEQUENCING MARKET RESEARCH PROCESS
FIGURE 4. WHOLE PLASMID SEQUENCING MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 11. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 13. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 15. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 17. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 19. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 21. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. WHOLE PLASMID SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 27. WHOLE PLASMID SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. WHOLE PLASMID SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. WHOLE PLASMID SEQUENCING MARKET DYNAMICS
TABLE 7. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY PLASMID-EZ, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY PRIMER WALKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENE MAPPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL WHOLE PLASMID SEQUENCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 75. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 76. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 77. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 78. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 82. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 83. CANADA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 86. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 93. MEXICO WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES WHOLE PLASMID SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 127. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 128. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 129. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 130. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 132. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 134. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 135. CHINA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 137. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 138. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 139. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 140. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 144. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 145. INDIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 157. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 158. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 159. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 162. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 164. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 165. JAPAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 217. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 218. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 219. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 220. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 222. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 224. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 225. THAILAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 248. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 249. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 250. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 251. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 253. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 255. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 256. DENMARK WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 258. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 259. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 260. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 261. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 265. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 266. EGYPT WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 268. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 269. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 271. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 273. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 275. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 276. FINLAND WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 278. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 279. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 280. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 281. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 283. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 285. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 286. FRANCE WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 288. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 289. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 290. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 291. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 293. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 295. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 296. GERMANY WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 308. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 309. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 310. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 311. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 313. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 315. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 316. ITALY WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY GENETIC RESEARCH, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS WHOLE PLASMID SEQUENCING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 328. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA WHOLE PLASMID SEQUENCING MARKET SIZE, BY SAMPLE TYP

Companies Mentioned

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BaseClear B.V.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Danaher Corporation
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies
  • LGC Biosearch Technologies
  • Macrogen, Inc.
  • New England Biolabs
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Paragon Genomics, Inc.
  • Personalis Inc.
  • Polyplus-transfection S.A.
  • Qiagen N.V.
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 136.66 Million
Forecasted Market Value ( USD ) by 2030 $ 198.88 Million
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Sequencing Reagents Market by Type, by Technology, by Application, by End-user, and By Region - Product Image

Sequencing Reagents Market by Type, by Technology, by Application, by End-user, and By Region

  • Report
  • 200 Pages
  • Global
From
Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering Sequencing Type, Technology Application, End User - Global Forecast to 2031 - Product Image

Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering Sequencing Type, Technology Application, End User - Global Forecast to 2031

  • Report
  • 312 Pages
  • Global
From
Long Read Sequencing Market Size, Share & Trends by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029 - Product Image

Long Read Sequencing Market Size, Share & Trends by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029

  • Report
  • 307 Pages
  • Global
From
Metagenomics Market Size, Share, Forecast & Trends Analysis by Offering (Consumable, Instruments, Software), Technology (16S, Shotgun, Whole Genome Sequencing Microbial Sequencing), Application (Environmental, Clinical, Drug Discovery) - Global Forecast to 2031 - Product Image

Metagenomics Market Size, Share, Forecast & Trends Analysis by Offering (Consumable, Instruments, Software), Technology (16S, Shotgun, Whole Genome Sequencing Microbial Sequencing), Application (Environmental, Clinical, Drug Discovery) - Global Forecast to 2031

  • Report
  • 154 Pages
  • Global
From
Whole Exome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Whole Exome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.